Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...
He credited the medicine with keeping the atrial flutter in check. “If there’s any flare-up, then I’ll get the ablation,” ...
Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...
Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...
Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...
Stockhead on MSN15d
Basement to Breakthrough: Imricor transforms heart treatment with MRIImricor’s work over past 18 years developing the world’s only MRI-compatible devices for cardiac ablation procedures is ...
Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has ... isthmus-dependent atrial flutter. "The Affera system was designed to address ...
GlobalData on MSN21d
FDA approves Medtronic’s Affera mapping and ablation system with Sphere-9 catheterThis approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.
PFA is a new cardiac ablation technique to treat a common heart arrhythmia. Traditional ablation methods use heat or cold to scar heart tissue, blocking irregular signals, but PFA uses electrical ...
and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter. With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib.
and for RF ablation of cavotricuspid isthmus (CTI) dependent atrial flutter. With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback